30 April - 6 May 2016
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Zinbryta (daclizumab) nears approval in Europe
Gilenya (fingolimod) rebound risk
A case review of 46 people stopping Gilenya (fingolimod) found that five of them developed severe symptoms that were more aggressive than their level before starting treatment. The symptoms appeared within the usual washout period before another treatment is started and persisted despite treatment with steroids.
Source: MedPage Today
MS Trust link: Gilenya (fingolimod)
Suicide rates higher in MS
Swedish research looked at rates of suicide in a sample of 29,617 people with MS. There were 423 attempted suicides and 114 completed suicides. The rates for both attempted and successful suicides were roughly twice as high as in a control group of people who do not have MS.
Source: Neurology Advisor
MS Trust link: Depression